Analysts Bet Celebrex Won't Be Withdrawn
143159
Some analysts are betting Pfizer Inc.  PFE.N won't have to withdraw its arthritis drug Celebrex but  they do expect sales to fall after a study of the drug in  cancer patients showed it increased the risk of heart attacks.
277613
[India News]: New York, Dec 20 : America&#39;s multibillion dollar pharmaceutical industry has been shaken by reports that Pfizer&#39;s high-profile arthritis drug, Celebrex, is said to cause an increased risk of heart attack.
440029
Despite questions about heart risks, LeVella Yoder is willing to take her chances with the arthritis drug Celebrex. Without it, she said, she can&#39;t walk, type or make it through tax season as an accountant.
745709
At a research and development meeting for analysts on Nov. 30, Pfizer (PFE ) stayed on message all day long. Despite questions about possible safety issues with arthritis pain medication Celebrex, patent challenges
224987
Doctors should limit use of Pfizer Inc.&#39;s Celebrex and Bextra pain drugs while regulators continue to weigh their cardiovascular risks, the US Food and Drug Administration said.
377206
A study of the arthritis drug Celebrex casts doubt on the company's insistence that it had no hint of the drug's potential heart and stroke risks until recently.
496302
Pfizer Inc.&#39;s bid to head off a Celebrex recall may get a boost from new government data showing the painkiller didn&#39;t raise heart risks in a study, while Aleve, which is sold by Bayer AG, did, investors said.
395844
The good news about the latest blockbuster-drug debacle, this one involving the arthritis medication Celebrex, is that the consumer-protection system - such as it is - appears to have worked.
247867
Pfizer on Sunday reaffirmed its commitment to Celebrex, its blockbuster prescription medication for pain and inflammation from arthritis, despite a disclosure last week that the drug had increased the risk of heart attacks, strokes and death among some
483616
Pfizer Inc. may fall short in convincing federal regulators that its painkiller Celebrex should receive expanded approval to treat children with a devastating form of arthritis, according to documents released Tuesday.
84184
As the Food and Drug Administration prepares to make recommendations about Pfizer&#39;s (PFE:NYSE - news - research) Celebrex, the companies that ultimately pay for the drug aren&#39;t leaping to conclusions merely because one recent study showed patients taking
762997
For the people who have followed closely the unfolding concerns about popular arthritis medicines, the news that Celebrex may also be linked to a higher risk of stroke and heart attack holds little surprise.
261035
Pfizer Inc. shares rebounded on Tuesday as a study of Alzheimer&#39;s patients found that its arthritis drug Celebrex carried no increased cardiovascular risks, differing from
119087
Pfizer Inc. says it will immediately pull advertising for its top-selling arthritis pain reliever Celebrex, whose safety was called into question last week after a study found an increased risk of heart attacks in patients taking high dosages of the drug.
493704
Pfizer is pulling its radio, TV, newspaper and magazine advertising for Celebrex in the wake of a study that links high doses of the popular arthritis to an increased risk of heart attack, but the company plans to keep Celebrex on the market.
753455
Pfizer to investors: Don't stop believing.
725683
Pfizer Inc. said it found an increased risk of heart attacks and strokes for patients taking high dosages of its top-selling arthritis painkiller Celebrex -- the same problem that led to the withdrawal of its one-time competitor, Vioxx.